TAM
KYTH

Tocqueville Asset Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Tocqueville Asset Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-119,912
Closed -$8.99M – 997
2015
Q3 		$8.99M Sell
119,912
-142,635
-54% -$10.7M 0.12% 208
2015
Q2 		$19.8M Sell
262,547
-36,052
-12% -$1.93M 0.23% 132
2015
Q1 		$15M Buy
298,599
+9,005
+3% +$378K 0.18% 160
2014
Q4 		$10M Buy
289,594
+190,009
+191% +$6.63M 0.11% 212
2014
Q3 		$3.26M Buy
99,585
+6,095
+7% +$215K 0.04% 349
2014
Q2 		$3.59M Buy
93,490
+36,920
+65% +$1.29M 0.03% 375
2014
Q1 		$2.25M Buy
56,570
+8,350
+17% +$374K 0.03% 366
2013
Q4 		$1.8M Buy
+48,220
New +$2M 0.02% 393

Tocqueville Asset Management's KYTH Position: Q4 2015 in Review

Tocqueville Asset Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 119,912 shares — an estimated $8.99M sold.

Tocqueville Asset Management first reported a position in KYTH in Q4 2013 and held it in 8 quarters. The position peaked at $19.8M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Tocqueville Asset Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 119,912 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $8.99M.
  • Tocqueville Asset Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 8 quarters.
  • Tocqueville Asset Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $19.8M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Tocqueville Asset Management's 13F filing for Q4 2015, filed 29 Jan 2016.